Brind.
  1. Report covers clinical trials for Mycosis Fungoides involving Bristol-Myers Squibb, Johnson & Johnson, Merck, and Novartis.

Bristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.

2 reports, 1 independent Updated Sep 9
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Bristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.

Who's involved

What this event is mainly about
Bristol-Myers SquibbNovartis

Keep exploring

Part of

Report covers clinical trials for Mycosis Fungoides involving Bristol-Myers Squibb, Johnson & Johnson, Merck, and Novartis. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story